Concepedia
Statistics
Publications
46
Citations
4.2K
H-Index
31
Active since
1987
Affiliations
University of Cambridge(Current)
Pfizer (United Kingdom)
Pfizer (United States)
Addenbrooke's Hospital
MSD (UK) Limited (United Kingdom)
Mark J. Field is an author at University of Cambridge specializing in medicine, pharmacology, and neuropharmacology.
Top concepts
MedicinePharmacologyNeuropharmacologyNeurosciencePharmacotherapyDrug DiscoverySocial SciencesHealthPain MedicinePain Research
Publications per year
1987–2020
Identification of the α <sub>2</sub> -δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin
Mark J. Field, Peter J. Cox, Emma Stott et al. · Proceedings of the National Academy of Sciences · 2006 · 582 citations · Full text
Gabapentin (neurontin) and <b>S</b>‐(+)‐3‐isobutylgaba represent a novel class of selective antihyperalgesic agents
Mark J. Field, Ryszard J. Oles, Siân Lewis et al. · British Journal of Pharmacology · 1997 · 330 citations · Full text
Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat
Mark J. Field, Scott McCleary, John Hughes et al. · Pain · 1999 · 298 citations
Evaluation of Gabapentin and S-(+)-3-Isobutylgaba in a Rat Model of Postoperative Pain
Mark J. Field, Elizabeth F. Holloman, Scott McCleary et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 251 citations
The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed byd-serine
L. Singh, Mark J. Field, Pushpinder Ferris et al. · Psychopharmacology · 1996 · 232 citations
Antiepileptic Agent Gabapentin, Neurophysiology, Medicine +13
1–5 of 46